It’s Conference Season!

Welcome back to another episode of Wall Street Unplugged.

As you may know, I’ve been reporting live from the 2018 Consumer Electronics Show this week. And I’ve got some interesting observations to report…  

But on this week’s show, we’re going to focus on another major conference investors shouldn’t overlook: the annual J.P. Morgan Healthcare Conference. It’s attended by 400-plus biotech companies and over 10,000 industry professionals.

And today I’ve reached out to my No. 1 healthcare industry analyst, Marc Lichtenfeld, to give us the inside scoop.

Marc is Chief Income Strategist at The Oxford Club. He’s covered the biotech and healthcare sectors for over a decade.

Tune in as Marc talks about promising new drug development and innovation across the healthcare sector… and why he thinks biotech has finally reached an “inflection point.”

Marc also reveals two small-cap biotech companies with untapped potential.

Good Investing,

Frank Curzio

Download Transcript

RECENT EPISODES

oil market

How to profit from today’s volatile oil market

Steve Koomar is back to share his views on the Saudi oilfield attack. He also gives you some of his favorite energy names to buy right now... and which to avoid. Plus, Frank debunks the theory that higher oil prices will derail the U.S. consumer… and tells you how to invest in this volatile sector without a lot of risk.
Listen Now
inflection point

Don’t be passive at an inflection point like this

Two things are on my mind today: energy security and passive investing. We’ll explore why they’re linked… and the inflection point that’s been quietly building in the markets. Now more than ever, you can’t afford to be passive…
Listen Now